Nuclear factor-κB mediates the cell survival-promoting action of activity-dependent neurotrophic factor peptide-9

被引:73
作者
Glazner, GW
Camandola, S
Mattson, MP
机构
[1] NIA GRC 4F01, Neurosci Lab, Baltimore, MD 21224 USA
[2] Univ Kentucky, Sanders Brown Res Ctr Aging, Lexington, KY USA
[3] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA
[4] Univ Turin, Dept Med, Turin, Italy
关键词
activity-dependent neurotrophic factor; Alzheimer's disease; apoptosis; decoy DNA; hippocampus; oxidative stress; transcription;
D O I
10.1046/j.1471-4159.2000.0750101.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activity-dependent neurotrophic factor (ADNF) is produced by astrocytes in response to neuronal depolarization and, in turn, promotes neuronal survival. A nine-amino acid ADNF peptide (ADNF9) exhibits full neurotrophic activity and potently protects cultured embryonic rat hippocampal neurons from oxidative injury and apoptosis. Picomolar concentrations of ADNF9 induced an increase in nuclear factor-kappa B (NF-kappa B) DNA-binding activity within 1 h of exposure, with a maximum increase of similar to 10-fold by 6 h. Activation of NF-kappa B was correlated with increased resistance of neurons to apoptosis induced by exposure to Fe2+. The antiapoptotic action of ADNF9 was abolished when NF-kappa B activation was specifically blocked with kappa B decoy DNA. Oxidative stress was attenuated in neurons pretreated with ADNF9, and this effect of ADNF9 was blocked by kappa B decoy DNA, suggesting that ADNF9 suppresses apoptosis by reducing oxidative stress. ADNF9 also prevented neuronal apoptosis following trophic factor withdrawal via an NF-kappa B-mediated mechanism. Thus, NF-kappa B mediates the neuron survival/promoting effects of ADNF9 in experimental models relevant to developmental neuronal death and neurodegenerative disorders.
引用
收藏
页码:101 / 108
页数:8
相关论文
共 50 条
[1]   Immune and inflammatory responses in the CNS: modulation by astrocytes [J].
Aschner, M .
TOXICOLOGY LETTERS, 1998, 103 :283-287
[2]   ACTIVATION OF DNA-BINDING ACTIVITY IN AN APPARENTLY CYTOPLASMIC PRECURSOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR [J].
BAEUERLE, PA ;
BALTIMORE, D .
CELL, 1988, 53 (02) :211-217
[3]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[4]   TUMOR-NECROSIS-FACTOR-ALPHA AND TUMOR-NECROSIS-FACTOR-BETA PROTECT NEURONS AGAINST AMYLOID BETA-PEPTIDE TOXICITY - EVIDENCE FOR INVOLVEMENT OF A KAPPA-B-BINDING FACTOR AND ATTENUATION OF PEROXIDE AND CA2+ ACCUMULATION [J].
BARGER, SW ;
HORSTER, D ;
FURUKAWA, K ;
GOODMAN, Y ;
KRIEGLSTEIN, J ;
MATTSON, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9328-9332
[5]   Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide [J].
Bassan, M ;
Zamostiano, R ;
Davidson, A ;
Pinhasov, A ;
Giladi, E ;
Perl, O ;
Bassan, H ;
Blat, C ;
Gibney, G ;
Glazner, G ;
Brenneman, DE ;
Gozes, I .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) :1283-1293
[6]   A femtomolar-acting neuroprotective peptide [J].
Brenneman, DE ;
Gozes, I .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (10) :2299-2307
[7]  
Brenneman DE, 1998, J PHARMACOL EXP THER, V285, P619
[8]   Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors [J].
Bruce, AJ ;
Boling, W ;
Kindy, MS ;
Peschon, J ;
Kraemer, PJ ;
Carpenter, MK ;
Holtsberg, FW ;
Mattson, MP .
NATURE MEDICINE, 1996, 2 (07) :788-794
[9]   Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis [J].
Bushdid, PB ;
Brantley, DM ;
Yull, FE ;
Blaeuer, GL ;
Hoffman, LH ;
Niswander, L ;
Kerr, LD .
NATURE, 1998, 392 (6676) :615-618
[10]   Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75 [J].
Carter, BD ;
Kaltschmidt, C ;
Kaltschmidt, B ;
Offenhauser, N ;
BohmMatthaei, R ;
Baeuerle, PA ;
Barde, YA .
SCIENCE, 1996, 272 (5261) :542-545